KURE KraneShares MSCI All China Health Care Index ETF
This exchange-traded fund will allocate at least 80% of its net assets, including any capital acquired through borrowing for investment purposes, to financial instruments that are components of its underlying index or exhibit similar economic characteristics. The reference index is a market capitalization-weighted measure, adjusted for free float, and applies a 10/40 Constraint. Its objective is to gauge the equity market performance of Chinese enterprises within the healthcare sector. This fund does not maintain a diversified portfolio.
No price history on file.
Performance
| 1M | 3M | YTD | 1Y | 3Y ann. | 5Y ann. | |
|---|---|---|---|---|---|---|
| KURE | — | — | — | — | — | — |
| Equity average (4726 funds) | -2.7% | -5.4% | +5230.6% | +3368.6% | +15.4% | +3.4% |
Insider activity in the holdings
Open-market insider buying across this fund’s holdings over 90 days, weighted by holding weight: −$1K net.
| Holding | Weight | Insiders bought | Insiders sold |
|---|---|---|---|
| LEGN LEGEND BIOTECH CORP-ADR | 0.82% | $183K | $309K |
Holdings · as of Nov 13, 2026
| # | Holding | Weight |
|---|---|---|
| 1 | 6160.HK BEONE MEDICINES LTD | 9.64% |
| 2 | 1801.HK INNOVENT BIOLOGICS INC | 8.14% |
| 3 | 2269.HK WUXI BIOLOGICS CAYMAN INC | 7.56% |
| 4 | 603259.SS WUXI APPTEC CO LTD-A | 5.54% |
| 5 | 600276.SS JIANGSU HENGRUI PHARMACEUT-A | 4.48% |
| 6 | 300760.SZ SHENZHEN MINDRAY BIO-MEDIC-A | 4.30% |
| 7 | 9926.HK AKESO INC | 4.15% |
| 8 | 1177.HK SINO BIOPHARMACEUTICAL | 3.91% |
| 9 | 1093.HK CSPC PHARMACEUTICAL GROUP LT | 3.47% |
| 10 | 2359.HK WUXI APPTEC CO LTD-H | 3.19% |
| 11 | 3692.HK HANSOH PHARMACEUTICAL GROUP | 3.09% |
| 12 | 1548.HK GENSCRIPT BIOTECH CORP | 2.80% |
| 13 | 000538.SZ YUNNAN BAIYAO GROUP CO LTD-A | 2.42% |
| 14 | 688271.SS SHANGHAI UNITED IMAGING HE-A | 2.41% |
| 15 | 1530.HK 3SBIO INC | 2.11% |
| 16 | 6990.HK SICHUAN KELUN-BIOTECH BIOP-H | 2.09% |
| 17 | 300015.SZ AIER EYE HOSPITAL GROUP CO-A | 2.02% |
| 18 | 600436.SS ZHANGZHOU PIENTZEHUANG PHA-A | 1.95% |
| 19 | 002422.SZ SICHUAN KELUN PHARMACEUTIC-A | 1.85% |
| 20 | KURE SICHUAN BIOKIN PHARMACEUTI-A | 1.72% |
| 21 | 300759.SZ PHARMARON BEIJING CO LTD-A | 1.63% |
| 22 | 1099.HK SINOPHARM GROUP CO-H | 1.57% |
| 23 | 002653.SZ HAISCO PHARMACEUTICAL GROU-A | 1.31% |
| 24 | 002821.SZ ASYMCHEM LABORATORIES TIAN-A | 1.30% |
| 25 | 2228.HK XTALPI HOLDINGS LTD | 1.24% |
| 26 | 600196.SS SHANGHAI FOSUN PHARMACEUTI-A | 1.23% |
| 27 | 300832.SZ SHENZHEN NEW INDUSTRIES BI-A | 1.20% |
| 28 | 2268.HK WUXI XDC CAYMAN INC | 1.19% |
| 29 | 000963.SZ HUADONG MEDICINE CO LTD-A | 1.17% |
| 30 | 601607.SS SHANGHAI PHARMACEUTICALS-A | 1.14% |
| 31 | 000999.SZ CHINA RESOURCES SANJIU MED-A | 1.04% |
| 32 | 688617.SS APT MEDICAL INC-A | 1.03% |
| 33 | 688578.SS SHANGHAI ALLIST PHARMACEUT-A | 0.97% |
| 34 | 9995.HK REMEGEN CO LTD-H | 0.95% |
| 35 | 688331.SS REMEGEN CO LTD-A | 0.90% |
| 36 | 600085.SS BEIJING TONG REN TANG CO-A | 0.84% |
| 37 | 002294.SZ SHENZHEN SALUBRIS PHARM-A | 0.83% |
| 38 | LEGN LEGEND BIOTECH CORP-ADR | 0.82% |
| 39 | 002252.SZ SHANGHAI RAAS BLOOD PRODUC-A | 0.79% |
| 40 | 300765.SZ CSPC INNOVATION PHARMACEUT-A | 0.74% |
| 41 | 300896.SZ IMEIK TECHNOLOGY DEVELOPME-A | 0.67% |
| 42 | 300347.SZ HANGZHOU TIGERMED CONSULTI-A | 0.47% |
Sector breakdown
Not on file.
Country breakdown
Not on file.
Distributions
No distributions on file.
Members of Congress who disclosed this ETF
No member of Congress has disclosed a trade in KURE in the filings we hold.
Fund facts, prices, performance and distributions: our market-data vendor. Holdings: the vendor and SEC Form N-PORT. Insider and Congress data: InsiderBuying. Last updated Nov 17, 2026. This is historical data, not investment advice. Report a data error
